These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 20619664)

  • 21. Improving the quality of 3D-QSAR by using flexible-ligand receptor models.
    Pei J; Chen H; Liu Z; Han X; Wang Q; Shen B; Zhou J; Lai L
    J Chem Inf Model; 2005; 45(6):1920-33. PubMed ID: 16309299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Docking ligands onto binding site representations derived from proteins built by homology modelling.
    Schafferhans A; Klebe G
    J Mol Biol; 2001 Mar; 307(1):407-27. PubMed ID: 11243828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and synthesis of N-(3,3-diphenylpropenyl)alkanamides as a novel class of high-affinity MT2-selective melatonin receptor ligands.
    Bedini A; Spadoni G; Gatti G; Lucarini S; Tarzia G; Rivara S; Lorenzi S; Lodola A; Mor M; Lucini V; Pannacci M; Scaglione F
    J Med Chem; 2006 Dec; 49(25):7393-403. PubMed ID: 17149869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highly flexible ligand binding pocket of ecdysone receptor: a single amino acid change leads to discrimination between two groups of nonsteroidal ecdysone agonists.
    Kumar MB; Potter DW; Hormann RE; Edwards A; Tice CM; Smith HC; Dipietro MA; Polley M; Lawless M; Wolohan PR; Kethidi DR; Palli SR
    J Biol Chem; 2004 Jun; 279(26):27211-8. PubMed ID: 15107428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single point mutation in ecdysone receptor leads to increased ligand specificity: implications for gene switch applications.
    Kumar MB; Fujimoto T; Potter DW; Deng Q; Palli SR
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14710-5. PubMed ID: 12411578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, 3D-QSAR, and structural modeling of benzolactam derivatives with binding affinity for the D(2) and D(3) receptors.
    López L; Selent J; Ortega R; Masaguer CF; Domínguez E; Areias F; Brea J; Loza MI; Sanz F; Pastor M
    ChemMedChem; 2010 Aug; 5(8):1300-17. PubMed ID: 20544783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ecdysteroid ligand-receptor selectivity--exploring trends to design orthogonal gene switches.
    Lapenna S; Friz J; Barlow A; Palli SR; Dinan L; Hormann RE
    FEBS J; 2008 Dec; 275(23):5785-809. PubMed ID: 19021756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligand-based assessment of factor Xa binding site flexibility via elaborate pharmacophore exploration and genetic algorithm-based QSAR modeling.
    Taha MO; Qandil AM; Zaki DD; AlDamen MA
    Eur J Med Chem; 2005 Jul; 40(7):701-27. PubMed ID: 15935905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3D-QSAR CoMFA, CoMSIA studies on substituted ureas as Raf-1 kinase inhibitors and its confirmation with structure-based studies.
    Thaimattam R; Daga P; Rajjak SA; Banerjee R; Iqbal J
    Bioorg Med Chem; 2004 Dec; 12(24):6415-25. PubMed ID: 15556759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein structure based rational design of ecdysone agonists.
    Holmwood G; Schindler M
    Bioorg Med Chem; 2009 Jun; 17(12):4064-70. PubMed ID: 19168365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3D-QSAR and receptor modeling of tyrosine kinase inhibitors with flexible atom receptor model (FLARM).
    Peng T; Pei J; Zhou J
    J Chem Inf Comput Sci; 2003; 43(1):298-303. PubMed ID: 12546565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.
    Vivat V; Zechel C; Wurtz JM; Bourguet W; Kagechika H; Umemiya H; Shudo K; Moras D; Gronemeyer H; Chambon P
    EMBO J; 1997 Sep; 16(18):5697-709. PubMed ID: 9312028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-throughput screening of ecdysone agonists using a reporter gene assay followed by 3-D QSAR analysis of the molting hormonal activity.
    Wheelock CE; Nakagawa Y; Harada T; Oikawa N; Akamatsu M; Smagghe G; Stefanou D; Iatrou K; Swevers L
    Bioorg Med Chem; 2006 Feb; 14(4):1143-59. PubMed ID: 16249087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural and chemical basis for enhanced affinity and potency for a large series of estrogen receptor ligands: 2D and 3D QSAR studies.
    Salum Lde B; Polikarpov I; Andricopulo AD
    J Mol Graph Model; 2007 Sep; 26(2):434-42. PubMed ID: 17349808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel procedure for modeling ligand/receptor induced fit effects.
    Sherman W; Day T; Jacobson MP; Friesner RA; Farid R
    J Med Chem; 2006 Jan; 49(2):534-53. PubMed ID: 16420040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ligand binding is without effect on complex formation of the ligand binding domain of the ecdysone receptor (EcR).
    Greb-Markiewicz B; Fauth T; Spindler-Barth M
    Arch Insect Biochem Physiol; 2005 May; 59(1):1-11. PubMed ID: 15822096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
    Xu Y; Liu H; Niu C; Luo C; Luo X; Shen J; Chen K; Jiang H
    Bioorg Med Chem; 2004 Dec; 12(23):6193-208. PubMed ID: 15519163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling ligand-receptor interaction for some MHC class II HLA-DR4 peptide mimetic inhibitors using several molecular docking and 3D QSAR techniques.
    Wei HY; Tsai KC; Lin TH
    J Chem Inf Model; 2005; 45(5):1343-51. PubMed ID: 16180911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular modeling of histamine H3 receptor and QSAR studies on arylbenzofuran derived H3 antagonists.
    Dastmalchi S; Hamzeh-Mivehroud M; Ghafourian T; Hamzeiy H
    J Mol Graph Model; 2008 Jan; 26(5):834-44. PubMed ID: 17561422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interaction.
    Carlson KE; Choi I; Gee A; Katzenellenbogen BS; Katzenellenbogen JA
    Biochemistry; 1997 Dec; 36(48):14897-905. PubMed ID: 9398213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.